- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04013035
Cervical Length on Pregnancy Termination
July 8, 2019 updated by: Pınar Kadirogulları, Kanuni Sultan Suleyman Training and Research Hospital
The Impact of Fetal Viability and Cervical Length on Pregnancy Termination Outcomes in Nulliparous Second Trimester Pregnancies
Cervical length is used as a parameter to predict cervical insufficiency and onset of labor.
However, its role in predicting abortion induction is unclear.To investigate the impact of cervical length measurement and fetal viability on second trimester pregnancy termination duration in nulliparous pregnant women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Cervical length and fetal viability were evaluated prior to second trimester pregnancy termination due to various indications.
nulliparous pregnant women through 13 and 26 gestational weeks in whom pregnancy termination was conducted within 72 hours after admission were included in the study.
The subjects were grouped into two groups according to fetal viability.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 33404
- Kanuni Sultan Suleyman Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Nulliparous pregnant women at 13-26 weeks of gestation will be included in the study.
Description
Inclusion Criteria:
-Nulliparous pregnant women at 13-26 weeks of gestation
Exclusion Criteria:
- Patients with multiple gestations,
- multiparous patients or
- patients that had uterine gynecologic surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cervical length measurement
Time Frame: 2 days
|
cervical length measurement at second trimester pregnancy termination in nulliparous pregnant women.
The measurements will be saved as a number in cm.
|
2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
June 1, 2017
Study Completion (Actual)
June 1, 2017
Study Registration Dates
First Submitted
July 7, 2019
First Submitted That Met QC Criteria
July 7, 2019
First Posted (Actual)
July 9, 2019
Study Record Updates
Last Update Posted (Actual)
July 10, 2019
Last Update Submitted That Met QC Criteria
July 8, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2015.01.01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Loss
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Conceptra Biosciences, LLCCompletedEarly Pregnancy Loss, Delayed Pregnancy LossUnited States
-
Suleyman Demirel UniversityNot yet recruiting
-
Hospital Clinic of BarcelonaEMDR EuropeCompleted
-
University Hospital, ToulouseCompleted
-
Wake Forest University Health SciencesWithdrawnRecurrent Pregnancy Loss Without Current Pregnancy
-
Bagcilar Training and Research HospitalCompletedRecurrent Pregnancy Loss Without Current PregnancyTurkey
-
Caroline Nørgaard-PedersenAalborg University Hospital; Department of Clinical Immunology, Odense University...CompletedRecurrent Pregnancy Loss, Not PregnantDenmark
-
Shenyang Medical CollegeCentral Hospital Affiliated to Shenyang Medical Collage; The Second Hospital...CompletedAnxiety Disorder | Recurrent Pregnancy Loss Without Current PregnancyChina
-
Hospital de Clinicas de Porto AlegreUNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL (UFRGS)RecruitingRecurrent Pregnancy Loss(RPL)Brazil
Clinical Trials on cervical length measurement
-
Saint Thomas Hospital, PanamaCompletedPregnancy, Prolonged | Cervical Length MeasurementPanama
-
University of LiverpoolLiverpool Women's NHS Foundation TrustCompletedPreterm BirthUnited Kingdom
-
Henry Ford Health SystemRecruitingPreterm Birth | Cervical Insufficiency | Cervical Length MeasurementUnited States
-
Acibadem UniversityCompleted
-
Ningbo UniversityThe Affiliated Ningbo Women and Children's Hospital of Ningbo University; Yinzhou...Not yet recruiting
-
Federico II UniversityRecruiting
-
Hospital Clinic of BarcelonaCompletedCervical Length | Labor, PrematureSpain
-
Ain Shams Maternity HospitalCompletedCervical DystociaEgypt
-
Beni-Suef UniversityCompletedPreterm PregnancyEgypt
-
Danone Asia Pacific Holdings Pte, Ltd.KK Women's and Children's HospitalCompletedGrowth; Stunting, NutritionalSingapore